Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
SLE;T-cells Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127-/low regulatory T cells in patients with active systemic lupus erythematosus
Arthritis & Rheumatism, 06/30/08
Print     Email This Article     Save in My Library   Free Abstract
Chowdary Venigalla RM et al. – In human systemic lupus erythematosus (SLE), impaired sensitivity of responder T (Tresp) cells to the suppressive effects of a comparably functional, highly purified natural Treg (nTreg) cell population leads to a defective suppression of T cell proliferation in active SLE.

Methods
  • Study to analyze the phenotype and function of CD4+,CD25high,CD127-/low nTreg cells isolated from the peripheral blood of patients with SLE
  • CD4+,CD25high,CD127-/low nTreg cells and CD4+,CD25- responder T (Tresp) cells from SLE pts SLE and normal donors were separated by FACS
  • Cell proliferation was quantified by 3H-thymidine incorporation, and immunophenotyping of the cells was done using FACScan

Results
  • Comparable percentages of CD4+,CD25high,FoxP3+ T cells were observed in pts with SLE and normal donors
  • Proliferation of SLE nTreg cells sorted into the subset CD4+,CD25high,CD127-/low was decreased vs SLE nTreg cells sorted into the subset CD4+,CD25high
  • While in normal donors, these values were 802 ± 177 cpm and 2,028 ± 548 cpm, respectively, confirming that effector cell contamination was reduced
  • Suppressive activity of nTreg cells was intact in all groups
  • CD4+,CD25- Tresp cells isolated from pts with active SLE were less sensitive vs pts with inactive SLE to the suppressive function of autologous or normal donor CD4+,CD25high,CD127-/low nTreg cells
  • An inverse correlation between the extent of T cell regulation in suppressor assays and the level of lupus disease activity

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.